New population health PAD screening promotion To support the vascular community to help save limbs and save lives through PAD and CLI detection, Biomedix® is offering a new promotion. The promotion includes: 1 x 4th-Generation PADnet® system 4 x PADnet …
Study Links Depression To Higher Rate of Negative PAD Outcomes The results of recent retrospective study published in the <a href=”https://doi.org/10.1016/j.avsg.2021.01.025″>Annals of Vascular Surgery</a> found that patients with Chronic Limb Threatening Ischemia (CLTI) tended to have worse outcomes if they …
April is Limb Loss and Limb Difference Awareness Month – Request A Media Kit Did you know that April is limb loss and limb difference awareness month? To help further the awareness of limb loss and educate on how to …
March is National Kidney Month – Request A Media Kit March is national kidney month, highlighting awareness of chronic kidney disease, which impacts 1 in 3 with diabetes and 1 in 5 with high blood pressure. To help further the …
Expands Biomedix Population Health Management Solution Today IRIS and Biomedix announced the signing of a strategic partnership agreement that expands the Biomedix Xchange Population Health Management Solution to include the testing, diagnosis and care planning for diabetic retinopathy examinations. “For …
Biomedix is proud to partner with the Association of Black Cardiologists to recognize that February is Black History Month and American Heart Month. All new and existing members of the Association of Black Cardiologists qualify for a $1,000 discount off …
Biomedix had the opportunity to support a PAD screening initiative at a large Skilled Nursing Facility (SNF). The SNF consisted of a variety of residents, including long-term care, short-term rehabilitation and recovery, and a dementia unit. This screening program was …
A recent study published in Diabetes Care highlighted the relationship between social deprivation and the incidence of diabetes-related foot disease, including lower-extremity amputation, peripheral artery disease, and peripheral neuropathy. This population-based retrospective cohort used data from 2005 through 2019, analyzing …
Every year, the reimbursement of PAD tests change. We provide an updated schedule each year to help you plan for the year ahead.
